Medicare Enrolled
Dr. Vincent Olorunnisomo, M.D.
Urology Physician · Joliet, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Olorunnisomo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Olorunnisomo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Olorunnisomo
Dr. Vincent Olorunnisomo is an urology physician in Joliet, IL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Olorunnisomo performed 2,285 Medicare services across 1,350 unique beneficiaries.
Between the years covered by Open Payments, Dr. Olorunnisomo received a total of $4,098 from 48 pharmaceutical and/or device companies across 189 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Olorunnisomo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 38% volume in IL
$4,098 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,285
Medicare services
Top 38% in IL for urology physician
1,350
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~143 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
567 | $2 | $17 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
400 | $95 | $205 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
302 | $8 | $84 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
247 | $33 | $88 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
113 | $122 | $280 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
82 | $8 | $19 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
75 | $66 | $133 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
52 | $181 | $748 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
51 | $56 | $134 |
| PSA test (prostate cancer screening) | 48 | $18 | $78 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
38 | $108 | $248 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
37 | $8 | $45 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
31 | $20 | $415 |
| Ertapenem sodium injection, 500 mg An injection of ertapenem sodium, an antibiotic medication, administered at a dose of 500 mg. |
28 | $11 | $144 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
23 | $70 | $191 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $77 | $201 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
19 | $33 | $88 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
19 | $33 | $88 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
19 | $33 | $88 |
| Antimicrobial drug evaluation Assessment of the patient's response to antibiotic, antifungal, or antiviral therapy. |
18 | $7 | $28 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
15 | $12 | $62 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $142 | $314 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
14 | $18 | $55 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
14 | $8 | $37 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
13 | $121 | $1,782 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
12 | $116 | $457 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
11 | $243 | $904 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
17.0% medium
82.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,098
Total received (2018-2024)
Avg $585/year across 7 years
Top 38% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
189
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,714 (90.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$322 (7.9%)
Other
Charitable contributions, space rental, and other categories
$63 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$23
2023
$834
2022
$869
2021
$793
2020
$315
2019
$617
2018
$648
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$23
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,092
Boston Scientific Corporation
$325
AstraZeneca Pharmaceuticals LP
$201
Travere Therapeutics, Inc.
$192
Endo Pharmaceuticals Inc.
$154
Olympus America Inc.
$129
PFIZER INC.
$129
Medtronic, Inc.
$122
Agiliti Surgical, Inc.
$108
Coloplast Corp
$100
Myriad Genetic Laboratories, Inc.
$91
Janssen Biotech, Inc.
$89
Clarus Therapeutics Inc.
$84
AbbVie, Inc.
$81
BOSTON SCIENTIFIC CORPORATION
$79
Myovant Sciences Inc.
$76
Retrophin, Inc.
$63
Baxter Healthcare
$63
Bayer Healthcare Pharmaceuticals Inc.
$61
TOLMAR Pharmaceuticals, Inc.
$60
UROVANT SCIENCES INC
$58
Merck Sharp & Dohme LLC
$58
Antares Pharma, Inc.
$56
ABBVIE INC.
$50
180 Medical, Inc.
$48
Roche Diagnostics Corporation
$41
Axonics, Inc.
$39
Teleflex LLC
$38
Bayer HealthCare Pharmaceuticals Inc.
$35
Dendreon Pharmaceuticals LLC
$32
NeoTract Inc.
$32
Sumitomo Pharma America, Inc.
$29
AbbVie Inc.
$25
COLOPLAST CORP
$25
Mission Pharmacal Company
$24
Mallinckrodt LLC
$24
Supernus Pharmaceuticals, Inc.
$21
GENZYME CORPORATION
$20
C. R. Bard, Inc. & Subsidiaries
$20
Axonics Modulation Technologies, Inc.
$19
TherapeuticsMD, Inc.
$15
Telix Pharmaceuticals
$15
Merck Sharp & Dohme Corporation
$14
DENTSPLY IH Inc.
$13
PROCEPT BioRobotics Corporation
$12
Zyla Life Sciences, Inc.
$12
Medtronic USA, Inc.
$12
Allergan, Inc.
$11
Top 3 companies account for 39.5% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ALTIS · AMS · ANNOVERA · AQUABEAM ROBOTIC SYSTEM · AVEED · AXIS · Androgel · Axonics · Axonics r-SNM System · BOTOX · Bard Urinary Drainage Bag · ELIGARD · ERLEADA · FLEXIVA · GEMTESA · GENERAL BPH · General - Erectile Dysfunction · ILLUCCIX · INTERSTIM · JATENZO · JEVTANA · KEYTRUDA · LYNPARZA · LoFric · Lupron · Lupron Depot · MD cobas Instruments and Reagents · MYRBETRIQ · Myrbetriq · Nubeqa · OES CYSTONEPHROFIBERSCOPE · OFIRMEV · ORGOVYX · ORIAHNN · PROVENGE · Prolaris · RESTORELLE · ReTrace · SOLYX · SPEEDICATH · SPRIX · Soltive · SpaceOAR VUE System - 10mL · TLANDO · TOVIAZ · Thiola · UPSYLON · UROLIFT · Uribel · UroLift · UroLift System · VESICARE · VIAGRA · VIRTUE · XIAFLEX · XTANDI · XYOSTED · Xtandi · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
46
Per 100K population
6.6
County median income
$107,799
Nearest hospital
SAINT JOSEPH MEDICAL CENTER
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Olorunnisomo is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Olorunnisomo experienced with automated urinalysis?
Based on Medicare claims data, Dr. Olorunnisomo performed 567 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Olorunnisomo receive payments from pharmaceutical companies?
Yes. Dr. Olorunnisomo received a total of $4,098 from 48 companies across 189 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Olorunnisomo's costs compare to other urology physicians in Joliet?
Dr. Olorunnisomo's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Olorunnisomo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Joliet
Browse urology physicians in Joliet ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology